RDY Neutral Sentiment Score: 47/100
Dr. Reddy's Laboratories Ltd . 8-2-337, Road No. 3, Banjara Hills Hyderabad - 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.
Saturday, May 17, 2025 1 min read
Key Takeaway: Dr. Reddy's Laboratories has reported that the USFDA completed a GMP inspection at their API Middleburgh facility in New York from May 12th to May 16th, 2025. The inspection concluded with the issuance of a Form 483, which contains two observations that the company needs to address within a specified timeline. The announcement highlights the company's commitment to compliance and regulatory standards.
Full Press Release Details
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
This is to inform you that the United States Food & Drug Administration (USFDA) completed a GMP inspection at our API Middleburgh facility in New York. The inspection was conducted from 12th May, 2025 to 16th May, 2025 (US EST time). We have been issued a Form 483 with 2 observations, which we will address within the stipulated timeline.
This is for your information and record.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer & Head-CSR